ClinicalTrials.gov
ClinicalTrials.gov Menu

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01796197
Recruitment Status : Active, not recruiting
First Posted : February 21, 2013
Last Update Posted : September 10, 2018
Sponsor:
Information provided by (Responsible Party):
Beth Overmoyer MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : March 2020